State Street’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.4M Sell
1,035,648
-31,127
-3% -$343K ﹤0.01% 2511
2025
Q1
$9.53M Sell
1,066,775
-155,695
-13% -$1.39M ﹤0.01% 2551
2024
Q4
$11.5M Buy
1,222,470
+30,849
+3% +$290K ﹤0.01% 2544
2024
Q3
$9.6M Sell
1,191,621
-75,754
-6% -$611K ﹤0.01% 2632
2024
Q2
$10.7M Sell
1,267,375
-101,406
-7% -$860K ﹤0.01% 2518
2024
Q1
$12.3M Sell
1,368,781
-21,533
-2% -$193K ﹤0.01% 2453
2023
Q4
$15.6M Sell
1,390,314
-80,873
-5% -$909K ﹤0.01% 2333
2023
Q3
$12.7M Sell
1,471,187
-6,101
-0.4% -$52.7K ﹤0.01% 2444
2023
Q2
$15.3M Buy
1,477,288
+66,280
+5% +$686K ﹤0.01% 2410
2023
Q1
$15.3M Sell
1,411,008
-21,911
-2% -$238K ﹤0.01% 2406
2022
Q4
$16.1M Sell
1,432,919
-51,840
-3% -$582K ﹤0.01% 2397
2022
Q3
$15.1M Sell
1,484,759
-10,287
-0.7% -$104K ﹤0.01% 2434
2022
Q2
$13.5M Sell
1,495,046
-46,487
-3% -$421K ﹤0.01% 2512
2022
Q1
$14.7M Buy
1,541,533
+181,331
+13% +$1.73M ﹤0.01% 2601
2021
Q4
$15M Sell
1,360,202
-12,045
-0.9% -$133K ﹤0.01% 2666
2021
Q3
$10.2M Buy
1,372,247
+116,189
+9% +$860K ﹤0.01% 2881
2021
Q2
$18.2M Buy
1,256,058
+103,439
+9% +$1.5M ﹤0.01% 2572
2021
Q1
$23.5M Buy
1,152,619
+103,274
+10% +$2.11M ﹤0.01% 2264
2020
Q4
$18.6M Sell
1,049,345
-42,339
-4% -$752K ﹤0.01% 2278
2020
Q3
$16.1M Sell
1,091,684
-14,147
-1% -$209K ﹤0.01% 2154
2020
Q2
$23.2M Buy
1,105,831
+50,563
+5% +$1.06M ﹤0.01% 1947
2020
Q1
$24.4M Buy
1,055,268
+95,704
+10% +$2.21M ﹤0.01% 1723
2019
Q4
$24.8M Buy
959,564
+11,948
+1% +$309K ﹤0.01% 1992
2019
Q3
$18.5M Buy
947,616
+9,112
+1% +$178K ﹤0.01% 2107
2019
Q2
$15.3M Buy
938,504
+34,750
+4% +$567K ﹤0.01% 2270
2019
Q1
$20.5M Buy
903,754
+22,108
+3% +$501K ﹤0.01% 2025
2018
Q4
$22.6M Sell
881,646
-2,152
-0.2% -$55.1K ﹤0.01% 1896
2018
Q3
$28.9M Buy
883,798
+6,405
+0.7% +$209K ﹤0.01% 1922
2018
Q2
$19.9M Buy
877,393
+15,942
+2% +$362K ﹤0.01% 2134
2018
Q1
$20.9M Sell
861,451
-21,645
-2% -$525K ﹤0.01% 2027
2017
Q4
$24.6M Sell
883,096
-30,740
-3% -$857K ﹤0.01% 1901
2017
Q3
$31.3M Buy
913,836
+24,154
+3% +$827K ﹤0.01% 1700
2017
Q2
$35.4M Buy
889,682
+19,428
+2% +$774K ﹤0.01% 1582
2017
Q1
$32M Buy
870,254
+19,230
+2% +$708K ﹤0.01% 1604
2016
Q4
$27.1M Buy
851,024
+131,646
+18% +$4.2M ﹤0.01% 1671
2016
Q3
$26.1M Buy
719,378
+9,807
+1% +$355K ﹤0.01% 1597
2016
Q2
$16.1M Buy
709,571
+165,364
+30% +$3.75M ﹤0.01% 1914
2016
Q1
$10.2M Buy
544,207
+15,574
+3% +$293K ﹤0.01% 2157
2015
Q4
$8.66M Sell
528,633
-254,231
-32% -$4.16M ﹤0.01% 2269
2015
Q3
$8.61M Sell
782,864
-80,414
-9% -$884K ﹤0.01% 2249
2015
Q2
$11.2M Sell
863,278
-141,631
-14% -$1.84M ﹤0.01% 2196
2015
Q1
$17.4M Buy
1,004,909
+44,749
+5% +$776K ﹤0.01% 1927
2014
Q4
$14.3M Sell
960,160
-151,877
-14% -$2.27M ﹤0.01% 1999
2014
Q3
$25.6M Buy
1,112,037
+517,179
+87% +$11.9M ﹤0.01% 1555
2014
Q2
$19M Buy
+594,858
New +$19M ﹤0.01% 1836